Brought to you by 
Almirall buys Aqua Pharmaceuticals
29 Jan 2014
Executive Summary
PE Firm RoundTable Healthcare has sold closely held US specialty dermatology company Aqua Pharmaceuticals LLC to Barcelona-headquartered Almirall SA for $327.6mm in cash up front (including $22.6mm pertaining to the amortization of long-term tax assets) and $75mm in potential regulatory and commercialization earn-outs expected to be reached in 2014-5. Almirall will not assume Aqua’s debt.
Deal Industry
- Pharmaceuticals
-
Pharmaceuticals
- Specialty Pharmaceuticals
-
Drug Delivery
- Topical Delivery
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Includes Earnout
- Payment Includes Cash
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Almirall buys Aqua Pharmaceuticals
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice